A Study of Vemurafenib in Metastatic Melanoma Participants With Brain Metastases

NCT01378975 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Melanoma

Interventions

DRUG: Vemurafenib

Sponsor

Hoffmann-La Roche